These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An Update on Herbal Products for the Management of Inflammatory Bowel Disease. Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699 [TBL] [Abstract][Full Text] [Related]
7. TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis. Solitano V; Jairath V; Ungaro F; Peyrin-Biroulet L; Danese S Med; 2024 May; 5(5):386-400. PubMed ID: 38574740 [TBL] [Abstract][Full Text] [Related]
8. [Polyphenols in the treatment of inflammatory bowel diseases]. Chojnacka K; Laskowska J Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320 [TBL] [Abstract][Full Text] [Related]
9. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595 [TBL] [Abstract][Full Text] [Related]
10. Diet, Food, and Nutritional Exposures and Inflammatory Bowel Disease or Progression of Disease: an Umbrella Review. Christensen C; Knudsen A; Arnesen EK; Hatlebakk JG; Sletten IS; Fadnes LT Adv Nutr; 2024 May; 15(5):100219. PubMed ID: 38599319 [TBL] [Abstract][Full Text] [Related]
11. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review. Alimohammadi N; Koosha F; Rafeian-Kopaei M Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220 [TBL] [Abstract][Full Text] [Related]
12. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184 [TBL] [Abstract][Full Text] [Related]
13. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734 [TBL] [Abstract][Full Text] [Related]
14. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review. Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723 [TBL] [Abstract][Full Text] [Related]